DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Rad Oncology Homepage

Emory University opens first proton therapy center in Georgia 28th PT center in the U.S.

Elekta Unity MR-linac gains FDA 510(k) clearance Simultaneously delivers radiation dose and visualization of tumors

Dr. Hermann Requardt United Imaging Healthcare appoints senior scientific advisor

Patient denied proton therapy dies, family received $25 million in court Points to the need for greater treatment coverage for certain cancer patients

Microbeam radiation therapy could lead to single session treatments Healthy cells tolerate treatment while tumors lose structure

CMS to unveil mandatory payment model for radiation oncology Part of determining approach that saves more and offers greater quality

European report says radiotherapy 'undervalued' and needing 'greater investment' Equipment shortages, lack of investment, training variations

ViewRay to supply UK's GenesisCare with country's first MRIdian systems Providing soft-tissue imaging in real time and better tumor targeting

Accuray showcases software upgrades for CyberKnife and Radixact at ASTRO Allows for 40 percent faster treatment delivery

Precision cancer care with proton and radiation oncology Some of the latest systems and software entering the market

3-D marker allows for faster, better breast cancer radiotherapy

by John W. Mitchell , Senior Correspondent
A bioabsorbable, three-dimensional marker implanted in a breast tumor bed reduces the amount of radiation that normal and surrounding tissue receives — as well as the length of radiation treatments — resulting in better outcomes.

"I have been doing breast conservation surgery for many years, and the worst part for patients often relates to the radiation required after surgery," Dr. Michael Cross, founder and medical director at the Breast Treatment Center in Fayetteville, AR, told HCB News. "When I first learned there was a new device to help target radiation, that could be used, and that there was potential for a shorter course of treatment with better targeting, I became really interested in trying the device on my patients."

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

The BioZorb marker is an implantable, bioabsorbable framework mounted with six titanium clips. The framework is slowly absorbed by the body in about a year. The remaining chips allow a three-dimensional view via imaging such as mammography.

Cross implanted the device in 108 women, average age 63, with early stage breast cancer over three years. The BioZorb device is sutured in place during lumpectomy surgery, allowing the surgeon to more precisely indicate to the radiation oncologist where the cancer was located.

"Once I started using the device routinely, we noticed the outcomes on our patients were much, much better and the radiation oncologists were able to transition to a shorter course of radiation known as hypofractionation," explained Cross. "The device helped to facilitate this by providing a more accurate method of targeting for radiation planning and delivery."

According to Cross, BioZorb permits hypofractionated radiation treatment with confidence, in the majority of patients. This means 21 days of radiation treatment, compared to 34 days (about a 60 percent reduction) currently required with standard whole breast irradiation.

"A lot of our patients travel back and forth quite a distance from home every day for their radiation treatment, some of them driving as much as 150 miles each way," said Cross. "So if their treatment is shorter, that's a very significant benefit to patients. It means less time away from family and work."

The biomarker also enables a technique known as "reconstructive lumpectomy", which improves the cosmetic appearance of the breast. Cross said this results in less swelling and fewer deformities among patients treated with BioZorb. He is planning a follow-up study on the cosmetic aspect of the treatment.

"In the end, I think the device will help to lower health care costs, primarily through making it easier to do a shorter course of hypofractionated radiation. While it's too early to say definitively, we are also seeing generally fewer complications and, as of three years out, no cancer recurrences have been seen in our study group," said Cross.

The results of his three-year research were published in the most recent issue of World Journal of Surgery.

Rad Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.